Question: is ivmed 80 launched in market?
Answer: Source: iVeena Delivery Systems iVeena Delivery Systems announced that the FDA has granted orphan drug designation for IVMED-80, for the treatment of keratoconus. IVMED-80 is the first eye-drop, non-surgical, non-laser treatment for medical crosslinking of the cornea.